Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).

Thomas, X; Fenaux, P; Dombret, H; Delair, S; Dreyfus, F; Tilly, H; Vekhoff, A; Cony-Makhoul, P; Leblond, V; Troussard, X; Cordonnier, C; de Revel, T; Simon, M; Nicolini, F; Stoppa, A M; Janvier, M; Bordessoule, D; Rousselot, P; Ffrench, M; Marie, J P; Archimbaud, E

Thomas, X; Fenaux, P; Dombret, H; Delair, S; Dreyfus, F; Tilly, H; Vekhoff, A; Cony-Makhoul, P; Leblond, V; Troussard, X; Cordonnier, C; de Revel, T; Simon, M; Nicolini, F; Stoppa, A M; Janvier, M; Bordessoule, D; Rousselot, P; Ffrench, M; Marie, J P; Archimbaud, E.

Affiliation

Thomas X; Department of Hematology, Hôpital Edouard Herriot, Lyon, France.

Leukemia ; 13(8): 1214-20, 1999 Aug.

Article in En | MEDLINE | ID: mdl-10450749

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Leukemia, Myeloid / Granulocyte-Macrophage Colony-Stimulating Factor Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links